Buckhead Capital Management LLC Boosts Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Buckhead Capital Management LLC raised its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 0.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 48,120 shares of the medical device company’s stock after purchasing an additional 152 shares during the quarter. Buckhead Capital Management LLC’s holdings in Cooper Companies were worth $4,424,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. State Street Corp lifted its holdings in shares of Cooper Companies by 1.2% in the 3rd quarter. State Street Corp now owns 8,590,689 shares of the medical device company’s stock valued at $947,897,000 after buying an additional 104,521 shares during the period. JPMorgan Chase & Co. lifted its holdings in Cooper Companies by 13.2% in the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock valued at $543,979,000 after acquiring an additional 573,908 shares during the period. Geode Capital Management LLC boosted its position in shares of Cooper Companies by 1.0% during the 3rd quarter. Geode Capital Management LLC now owns 4,796,556 shares of the medical device company’s stock worth $527,476,000 after purchasing an additional 48,559 shares in the last quarter. Victory Capital Management Inc. grew its stake in shares of Cooper Companies by 23.0% during the 3rd quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock worth $435,856,000 after purchasing an additional 737,726 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in shares of Cooper Companies by 11.9% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company’s stock valued at $200,665,000 after purchasing an additional 194,118 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently commented on COO. Citigroup decreased their price objective on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a report on Friday, December 6th. StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Wells Fargo & Company raised their price objective on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Finally, Morgan Stanley dropped their price target on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research report on Friday, December 6th. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $117.00.

Cooper Companies Stock Up 1.8 %

Shares of NASDAQ:COO opened at $93.68 on Friday. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $18.70 billion, a P/E ratio of 48.04, a P/E/G ratio of 2.41 and a beta of 1.00. The Cooper Companies, Inc. has a 52-week low of $84.76 and a 52-week high of $112.38. The stock’s fifty day simple moving average is $94.15 and its 200-day simple moving average is $99.76.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm’s quarterly revenue was up 9.8% on a year-over-year basis. During the same period in the prior year, the firm earned $0.87 EPS. As a group, equities research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.